TW201304815A - Cosmetics containing orchid embryo extracts - Google Patents

Abstract

A cosmetic includes at least one cosmetic material and at least one orchid embryo extract added therein to produce a cosmetic composition. The orchid embryo extract has a group of high performance genes to generate a composition which has an advantage of human skin.

Description

Cosmetic containing orchid embryo

The present invention relates to a cosmetic containing an orchid embryo extract; in particular, to a cosmetic comprising an extract of the high-performance gene group orchid embryonicin.

Conventional patent application, which discloses a cosmetic composition containing an orchid extract, such as COSMETIC OR DERMATOLOGICAL COMPOSITION CONTAINING AN ORCHID EXTRACT, AND COSMETIC CARF METHOD USING SAID COMPOSITION 美国, US Patent Application Publication No. 20110002968 And treating the skin care method using the cosmetic composition.

Another use of an orchid-containing extract cosmetic, such as US Patent Application Publication No. 20090258093, uses of a brassocattleya marcella koss orchid extract as an active agent to prevent or delay the appearance of signs of cutaneous aging 〞 invention patent application, which discloses An orchid extract is used as an activator to prevent or delay skin aging.

Another conventional use of an orchid-containing extract cosmetic, such as US Patent Application Publication No. 20090238848, uses of an extract of the Orchid Vanda Coerulea as a Skin Hydrating Agent, an invention patent application, which discloses a large flower of Vanda Coerulea [Vanda Coerulea] The extract acts as a skin moisturizer.

Another conventional use of an orchid-containing extract cosmetic, such as the genus Brassocattleya marcella koss orchid extract and use thereof as skin depigmentation, is disclosed in US Patent Application Publication No. 20090232758, which discloses the use of orchid extract as a skin spot removal.

However, the aforementioned U.S. Patent Application Publication Nos. 20110002968, No. 20090258093, No. 20090238848, and No. 20090232758 disclose only orchid extract as various skin care treatments, which do not disclose how the orchid embryo extract can be used for skin care purposes. Therefore, there is a need to further provide a more skin-care product with the use of orchid-containing extract cosmetics. The above-mentioned patent applications are only for reference to the technical background of the present invention and the state of the art is not intended to limit the present invention.

In view of the above, the present invention provides a cosmetic containing phalaenopsis embryos, which comprises a phalanum embryonicin added to a cosmetic raw material, and the phalaenopsis has at least one high-performance gene group to improve the use. The problem of poor cosmetic skin care.

The main object of the present invention is to provide a cosmetic containing phalaenopsis embryos, which comprises a phalaenopsis embryo in a cosmetic raw material, and the phalaenopsis has at least one high expression gene group for the purpose of improving the skin care effect.

In order to achieve the above object, the orchid-containing embryonin-containing cosmetic of the present invention comprises: at least one cosmetic raw material having a first predetermined content; and at least one orchid embryonicin having a second predetermined content, the orchid embryonic hormone being added In the cosmetic raw material, a cosmetic composition is prepared; wherein the orchid embryo has a high-performance gene group, which can produce a beneficial component to human skin.

In the preferred embodiment of the present invention, the cosmetic raw material is selected from a skin care product, a cosmetic material or a perfume material to be used as a skin care product, a color cosmetics or a perfume.

In a preferred embodiment of the invention, the orchid embryo is taken from an orchid embryo.

In a preferred embodiment of the invention, the orchid embryonicin has at least one high expression gene population.

The high performance gene group of the preferred embodiment of the invention comprises a replication/repair gene, a transcriptional gene, a cell division gene, a regulatory cell division gene, and an antioxidant related gene.

The cosmetic composition of the preferred embodiment of the present invention is a bio-cosmetic cosmetic.

In order to fully understand the present invention, the preferred embodiments of the present invention are described in detail below and are not intended to limit the invention.

According to Article 3 of the Regulations on Cosmetic Hygiene Management promulgated by the Department of Health of the Executive Yuan: The so-called cosmetics refers to "articles applied to the outside of the human body to moisturize the skin, stimulate the sense of smell, mask the body odor or modify the appearance". In fact, the definition of cosmetics may include a range of various maintenance products, a range of various cosmetic products or other beauty products, which are described in advance.

In general, the range of products covered by cosmetics can be divided into: skin care products, cosmetics and perfumes. For example, the skin care product comprises: a lotion, an emulsion, a face cream; the color cosmetics include: lipstick, eye shadow, blush, powder cake; the perfume comprises: essence, perfume, cologne, but it is not intended to limit the scope of the invention.

According to the functional use of the product, the definition of cosmetics includes: cosmetics for hair, cosmetics for shampoo, lotions, cosmetic oils, perfumes, powders, creams, bath cosmetics, Cosmetics for face washing, foundations, lipsticks, cosmetics for skin care, cosmetics for the eye, cosmetics for nails, and soaps are not intended to limit the scope of the present invention.

The cosmetic containing the orchid embryoin of the preferred embodiment of the present invention can be applied to various general cosmetics, including skin care products, cosmetics, and perfumes, but it is not intended to limit the scope of the present invention. Further, the cosmetic containing the orchid embryonin of the preferred embodiment of the present invention can be applied to the adsorption or absorption of human skin, but it is not intended to limit the scope of the present invention.

The specification of the present invention uses hydrazine adsorption [Adsorption] 〞 defined as a cosmetic component which can only stay on the surface of the stratum corneum; 〝 absorption [Absorption] 〞 is defined as a part of the cosmetic component penetrates the stratum corneum and reaches the deep layer of the epidermis, the dermis layer and even Within the subcutaneous tissue. For example, the composition of the cosmetic containing the orchid embryonin of the preferred embodiment of the present invention can be absorbed through the sweat gland of the human skin, the hair follicle mouth or crossing the keratinocytes or keratinocyte gaps.

BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a flow chart showing the extraction of orchid embryos using the preferred embodiment of the present invention. Referring to FIG. 1, the extraction process using phalaenopsis embryos in the preferred embodiment of the present invention comprises: firstly, planting orchid seeds in a growth medium to obtain orchid embryos. In particular, orchid seeds are preferably seeded and cultivated in 1/2 MS growth medium supplemented with inorganic salts and sugars.

Please refer to Fig. 1 again, and then, after a suitable growth period, remove the orchid embryo of the appropriate growth period [abbreviation: blue embryo]. The orchid embryo is ground or freeze-ground in an appropriate manner to obtain an appropriate amount of blue embryo powder. Thus, the blue embryo powder can be used for subsequent extraction of orchid embryonin and subsequent detection of its gene expression.

Referring again to Fig. 1, the blue embryo powder is then extracted in an appropriate manner [e.g., various extraction means] after the polishing is completed. In particular, the blue embryo powder is preferably selected for extraction at an aqueous solution at a temperature of 4 ° C to obtain an appropriate amount of the extraction solution.

Referring again to Fig. 1, then, after the aqueous extraction is completed, the extraction solution is separated in an appropriate manner. In particular, the extraction solution is preferably selected by a centrifugation technique (for example, a rotational speed of 13,000 rpm) for a predetermined time [for example, a rotational speed of 15 minutes] to obtain different water layers [for example, upper water or lower water]. The extraction solution was separated.

Referring to FIG. 1 again, after the separation is completed, the upper aqueous layer solution in the separated extraction solution is taken out from the separated extraction solution in an appropriate manner, and the orchid embryonin extract solution is taken out to prepare orchid embryonicin. [referred to as: blue embryo]. In particular, the orchid embryonin extract solution is preferably selected to be treated as a concentrated aqueous solution of lanolin by low temperature or dried to a blue pigment (powder).

Referring to Fig. 1 again, on the other hand, after the completion of the polishing, the extraction of the blue embryonic RNA [ribonucleic acid] from the blue embryo powder is carried out in an appropriate manner, as shown on the right side of Fig. 1. Next, the orchid embryo RNA is preferably selected to be expressed in an orchid oligo-biochip biomarker. Finally, the results of the test gene expression were analyzed to analyze the high-performing gene population in the blue embryo.

Fig. 2 is a view showing the relationship between the relative gene expression of the orchid embryo and the orchid leaf portion as reference values in the cosmetic of the preferred embodiment of the present invention. Referring to FIG. 2, the cosmetic of the preferred embodiment of the present invention uses orchid embryonicin to detect gene expression in an orchid oligo-biochip. In Fig. 2, the M value is the relative amount of the corrected amount of the orchid embryonic gene group corrected by the leaf.

Referring again to the upper half of Figure 2, the phalaenopsis embryonic gene group has a relatively high performance, and its M value is greater than zero, and the M group with a value greater than zero [ie, a high expression gene group] for human skin [ Human skin] has various good effects [for example: anti-oxidation], so the present invention uses orchid embryos to be added to various cosmetics.

Please refer to the lower half of Figure 2, on the other hand, the phalaenopsis embryo gene group still has a relatively low performance part, and the M value is less than zero, but the M value is less than zero gene group [ie low expression gene group] Part of the human skin does not have a special effect, so the gene group of the orchid embryoin of the present invention has a relatively better effect on human skin.

Figure 3 is a graph showing the expression of magnification of a high degree of gene expression in a cosmetic using phalaenopsis elastin in a preferred embodiment of the present invention, which is compared to the relative gene expression in Figure 2. Referring to FIG. 3, the high expression gene group of phalaenopsis embryos comprises a DNA replication/repair gene, a transcription gene, a cell division gene and a regulatory gene thereof, and an antioxidant related gene, and these genes belong to human skin. A beneficial high performance gene group with a maximum performance ratio of 14.9 and a minimum performance ratio of 2.0.

In the invention, the bio-chip is used to check the differential gene expression of the blue embryo and the leaf, and each differentially expressed gene taxonomic group has the function and quantity beneficial to the human skin, as shown in Table 1.

Fig. 4 is a flow chart showing the preparation of a cosmetic containing phalanin embryos according to a preferred embodiment of the present invention, which can be obtained by the extraction process of phalaenopsis obtained according to the extraction process of Fig. 1. Referring to FIG. 4, the cosmetic of the preferred embodiment of the present invention comprises at least one cosmetic raw material 11 and at least one orchid embryonicin 12. In the cosmetic, the cosmetic raw material 11 and the phalaenopsis embryo 12 have a first predetermined content and a second predetermined content, respectively.

Referring to Fig. 4 again, the phalanin 12 is added to the cosmetic material 11 to form a cosmetic composition 13. The phalaenopsis 12 has a high expression gene group that is beneficial to human skin. The cosmetic composition 13 of the present invention belongs to a living cosmetic.

The cosmetic raw material 11 used in the present invention is selected from a skin care product, a cosmetic material or a perfume material to be used as a skin care product, a color cosmetics or a perfume. The cosmetic raw material 11 can be roughly classified into two types of matrix raw materials and auxiliary raw materials according to their properties and uses. For example, the cosmetic universal matrix material comprises an oily raw material [including natural oily raw materials and synthetic oily raw materials], a silty raw material, a surfactant, a moisturizer, a binder, a preservative, an antioxidant, and a natural additive.

The foregoing preferred embodiments are merely illustrative of the invention and the technical features thereof, and the techniques of the embodiments can be carried out with various substantial equivalent modifications and/or alternatives; therefore, the scope of the invention is subject to the appended claims. The scope defined by the scope shall prevail.

11. . . Cosmetic raw materials

12. . . Orchid embryo

13. . . Cosmetic composition

Fig. 1 is a flow chart showing the extraction of orchid embryos using the preferred embodiment of the present invention.

Fig. 2 is a graph showing the relationship between the relative gene expression of orchid embryonics relative to orchid leaf parts in the preferred embodiment of the present invention.

Fig. 3 is a graph showing the performance magnification of a high degree of gene expression in the cosmetic of the preferred embodiment of the present invention.

Figure 4 is a flow chart showing the manufacture of a cosmetic containing orchid embryos in a preferred embodiment of the invention.

11. . . Cosmetic raw materials

12. . . Orchid embryo

13. . . Cosmetic composition

Claims (7)

A cosmetic containing phalaenopsis embryos, comprising: at least one cosmetic raw material having a first predetermined content; and at least one orchid embryonicin having a second predetermined content, the orchid embryonicin being added to the cosmetic raw material To produce a cosmetic composition; wherein the orchid embryo has a high performance gene group, which can produce beneficial ingredients for human skin. A cosmetic containing orchid embryonicin, comprising: an orchid embryonicin having a predetermined content, the orchid embryonic hormone is added to the cosmetic; wherein the orchid embryonic hormone has a high performance gene group, which can be produced on the human body A beneficial ingredient for the skin. The cosmetic containing orchid embryos according to claim 1, wherein the cosmetic raw material is selected from a skin care product, a cosmetic material or a perfume material to be used as a skin care product, a cosmetic product or a perfume. An orchid-containing embryonic preparation according to claim 1 or 2, wherein the orchid embryo is obtained from an orchid embryo. The garnetin-containing cosmetic according to claim 1 or 2, wherein the phalaenopsis has at least one high expression gene group. The cosmetic containing phalaenopsis embryos according to claim 5, wherein the high-performance gene group comprises a replication/repair gene, a transcription gene, a cell division gene, a regulation cell division gene, and an antioxidant-related gene. The cosmetic containing orchid embryos according to claim 1 or 2, wherein the cosmetic composition is a living cosmetic.